VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
HNGE
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
HNGEHinge Health, Inc.
$114.41$8.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksHNGEFinancials

Hinge Health, Inc. (HNGE) Income Statement

3Y historyFree accessUpdated daily

Revenue grew from $89.8M in 2024Q2 to $235.0M in 2026Q3 while gross margin expanded from 74.2% to 87.0%, though operating margin of 21.4% follows a $-6.1M operating loss in 2025Q3 and the 2025Q1 net income of $121.3M far exceeded $13.1M of operating income, warranting investigation of non-operating items.

Income StatementBalance SheetCash FlowRatios

HNGE Income Statement

Annual statement

HNGE Income Statement

Hinge Health, Inc. (HNGE) annual income statement — 3-year revenue, gross profit & net income history

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23
Sales/Revenue800.82M587.86M390.4M292.73M
Revenue Growth %49.86%50.58%33.37%-
Cost of Goods Sold114.14M118.56M89.81M98.55M
COGS % of Revenue-20.17%23%33.67%
Gross Profit686.68M469.3M300.59M194.18M
Gross Margin %85.75%79.83%77%66.33%
Gross Profit Growth %-56.13%54.8%-
Operating Expenses536.6M1.02B332.5M324.69M
OpEx % of Revenue-172.77%85.17%110.92%
Selling, General & Admin401.31M639.41M227.53M214.63M
SG&A % of Revenue-108.77%58.28%73.32%
Research & Development134.62M368.14M100.84M110.06M
R&D % of Revenue-62.62%25.83%37.6%
Other Operating Expenses665K8.12M4.13M0
Operating Income150.09M-546.37M-31.91M-130.51M
Operating Margin %18.74%-92.94%-8.17%-44.59%
Operating Income Growth %--1612.23%75.55%-
EBITDA155.77M-541.24M-25.96M-124.89M
EBITDA Margin %19.45%-92.07%-6.65%-42.66%
EBITDA Growth %128.45%-1984.89%79.21%-
D&A (Non-Cash Add-back)5.68M5.13M5.95M5.63M
EBIT158.68M-541.02M-24.43M-130.51M
Net Interest Income0000
Interest Income0000
Interest Expense0000
Other Income/Expense16.22M19.11M20.65M21.97M
Pretax Income166.31M-527.26M-11.26M-108.55M
Pretax Margin %20.77%-89.69%-2.88%-37.08%
Income Tax-2M998K677K-405K
Effective Tax Rate %-1.21%-0.19%-6.01%0.37%
Net Income168.31M-528.26M-11.93M-108.14M
Net Margin %21.02%-89.86%-3.06%-36.94%
Net Income Growth %139.23%-4326.89%88.97%-
Net Income (Continuing)168.31M-528.26M-11.93M-108.14M
Discontinued Operations0000
Minority Interest0000
EPS (Diluted)1.95-5.19-0.15-1.39
EPS Growth %135.8%-3360%89.21%-
EPS (Basic)--5.36-0.15-1.39
Diluted Shares Outstanding86.53M81.7M78.02M78.02M
Basic Shares Outstanding80.87M79.19M78.02M78.02M
Dividend Payout Ratio----

Key Metrics

Growth RegimeExpanding
ProfitabilityModerate
Balance SheetAdequate
Cash FlowImproving
Top Statement Risk

Operating margin not yet positive

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q3)

Sustained Top-Line Momentum Across Quarters

Based on reported figures, HNGE's revenue reached $235.0M in 2026Q3, up 52.4% year over year, suggesting growth has held near 50% for several consecutive quarters and remains durable at scale.

Quarterly revenue has compounded from $89.8M in 2024Q2 to $235.0M in 2026Q3, with year-over-year growth staying in a 45% to 55% band. This consistency suggests enterprise contract wins are converting into recognized revenue rather than reflecting a one-time step-up. Investors should monitor whether growth decelerates as the addressable employer base becomes more penetrated.

Gross Margin Expansion Supports Scalable Model

As reported in financial statements, HNGE's gross margin improved from 74.2% in 2024Q2 to 87.0% in 2026Q3, indicating that delivery costs are growing more slowly than subscription revenue.

The gross margin trajectory suggests the software and platform components are gaining weight in the revenue mix relative to clinical delivery costs. Whether this reflects AI-driven automation or favorable contract pricing cannot be determined from the reported figures alone. The margin level is strong by sector standards, though it must be weighed against the clinical labor embedded in cost of revenue.

Operating Leverage Emerging but Incomplete

Based on reported figures, HNGE's operating income swung from a $-6.1M loss in 2025Q3 to $50.3M in 2026Q3, with operating margin reaching 21.4%, indicating meaningful but uneven leverage.

SG&A has grown in absolute terms, rising to $116.5M in 2026Q3, yet operating income has expanded faster than revenue in recent quarters, which points to improving overhead absorption. The earlier 2025Q2 period, marked by a large $280.0M R&D charge, distorts the trend and should be treated as an outlier. Sustained leverage will depend on SG&A growth remaining below revenue growth.

Net Income Inflated by Non-Operating Items

According to recent SEC filings, HNGE's 2025Q1 net income of $121.3M far exceeded its $13.1M operating income, suggesting a material non-operating gain that warrants further investigation.

The gap between operating and net income in 2025Q1 implies non-operating or tax-related items that are not part of core business performance. Stock-based compensation, which reached $591.0M in 2025Q2 alongside a large R&D charge, appears to be a significant factor in reported earnings. Investors should separate recurring operating profit from these irregular items before extrapolating earnings trends.

Margin Gains Could Stall Under Platform Competition

Based on reported figures, HNGE's 52.4% revenue growth and 87.0% gross margin may not persist if large insurers bundle lower-cost digital physical therapy, a risk the recent quarters do not resolve.

The strongest bear case is that the recent margin expansion reflects favorable contract timing or capitalization choices rather than durable unit economics, which the reported figures alone cannot confirm. Operating margin of 21.4% in 2026Q3 follows a loss in 2025Q3, so a single quarter of profitability may not establish a trend. Investors should monitor whether SG&A growth stays below revenue growth and whether gross margin holds as enrollment scales.

HNGE — Frequently Asked Questions

Quick answers to the most common questions about buying HNGE stock.

What was Hinge Health, Inc.'s (HNGE) revenue in 2025?

For fiscal year 2025, Hinge Health, Inc. (HNGE) reported total revenue of $587.9M. This represents a 100.8% increase compared to $292.7M in 2023.

Is Hinge Health, Inc. (HNGE) profitable?

Hinge Health, Inc. (HNGE) reported a net loss of $528.3M for the fiscal year ending 2025.

What is Hinge Health, Inc.'s operating profit margin?

Hinge Health, Inc. (HNGE) reported an operating income of $-546.4M, resulting in an operating profit margin of -92.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Hinge Health, Inc.'s gross profit and gross margin?

Hinge Health, Inc. (HNGE) generated $469.3M in gross profit for the year, representing a gross profit margin of 79.8%. This demonstrates the company's core pricing power and production efficiency.